Top Markets
Coin of the day
Genetron Holdings Limited Genetron Holdings Limited

Genetron Holdings Limited

GTH
주식 순위 #15211
Genetron Holdings Limited (GTH) is a precision oncology company that... Genetron Holdings Limited (GTH) is a precision oncology company that specializes in cancer molecular profiling, utilizing advanced molecular biology and data science to enhance cancer treatment. The company delivers a range of services, including diagnosis, monitoring, and early screening, primarily through its proprietary laboratory-developed tests. Its product offerings encompass a variety of in-vitro diagnostic (IVD) solutions. These include the 8-gene lung cancer assay, an IVD product for lung cancer detection; the Genetron 3D biochip reading instrument; and the Genetron S5, a semiconductor-based next-generation sequencing (NGS) system that identifies nucleotides by detecting pH changes. Other key products are the Genetron Chef System, the production-scale Genetron S2000 sequencing platform, and Onco PanScan, a genomic profiling service for diverse solid tumors. Moreover, Genetron provides specialized assays such as the IDH1 and TERT gene assays for glioma, a fundamental thyroid assay for thyroid tumors, a platelet-derived growth factor receptor alpha assay for GIST cancer, and HCCscan, a qPCR-based assay designed to detect hepatocellular carcinoma. Beyond its direct services and products, the company offers genomics research and clinical development services, often in collaboration with biopharmaceutical companies globally. Genetron has also established a strategic partnership with JD Health to develop holistic solutions for comprehensive cancer management. The company was founded in 2015 and has its headquarters in Beijing, People's Republic of China.
주가
$4.03
마지막 동기화: 2024-03-28
시가총액
$366.11M
변동 (1일)
0.25%
변동 (1년)
0.00%
국가
CN
거래 Genetron Holdings Limited (GTH)

카테고리

Genetron Holdings Limited (GTH)의 수익
2026 기준 수익 TTM: 0
Genetron Holdings Limited의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Genetron Holdings Limited의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US